Your browser doesn't support javascript.
loading
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
Park, Sehhoon; Kim, Yu Jung; Min, Young Joo; Mortimer, Peter G S; Kim, Hee-Jung; Smith, Simon A; Dean, Emma; Jung, Hyun Ae; Sun, Jong-Mu; Park, Woong-Yang; Ahn, Jin Seok; Ahn, Myung-Ju; Lee, Se-Hoon; Park, Keunchil.
Afiliação
  • Park S; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim YJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Min YJ; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
  • Mortimer PGS; R&D Oncology, AstraZeneca, Cambridge, UK.
  • Kim HJ; External R&D, R&D Oncology, AstraZeneca, Seoul, Korea.
  • Smith SA; R&D Oncology, AstraZeneca, Cambridge, UK.
  • Dean E; R&D Oncology, AstraZeneca, Cambridge, UK.
  • Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Sun JM; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park WY; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cancer ; 130(4): 541-552, 2024 02 15.
Article em En | MEDLINE | ID: mdl-37843249
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Piperazinas / Pirimidinas / Sulfonamidas / Morfolinas / Carcinoma de Pequenas Células do Pulmão / Indóis / Neoplasias Pulmonares Limite: Female / Humans Idioma: En Revista: Cancer Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Piperazinas / Pirimidinas / Sulfonamidas / Morfolinas / Carcinoma de Pequenas Células do Pulmão / Indóis / Neoplasias Pulmonares Limite: Female / Humans Idioma: En Revista: Cancer Ano de publicação: 2024 Tipo de documento: Article